DNA methyltransferases as targets for cancer therapy.

Drugs of Today (Barcelona, Spain: 1998), 2007 - europepmc.org
Methylation of DNA at 5-position of cytosine, catalyzed by DNA methyltransferases, is the
predominant epigenetic modification in mammals. Aberrations in methylation play a causal …
被引用次数：193 相关文章

[引用][C] DNA methyltransferases as targets for cancer therapy.

K Ghoshal, S Bai - Medicamentos de actualidad= Drugs of today, 2007 - dialnet.unirioja.es

DNA METHYLTRANSFERASES AS TARGETS FOR CANCER THERAPY

K Ghoshal, S Bai - Drugs of Today, 2007 - access.portico.org
Methylation of DNA at 5-position of cytosine, catalyzed by DNA methyltransferases, is the
predominant epigenetic modification in mammals. Aberrations in methylation play a causal …

[引用][C] DNA methyltransferase as targets for cancer therapy

K Ghoshal, S Bai - Drugs of Today, 2007 - cir.nii.ac.jp

DNA methyltransferases as targets for cancer therapy

K Ghoshal, S Bai - Drugs of today (Barcelona, Spain …, 2007 - pubmed.ncbi.nlm.nih.gov
Methylation of DNA at 5-position of cytosine, catalyzed by DNA methyltransferases, is the
predominant epigenetic modification in mammals. Aberrations in methylation play a causal …

DNA methyltransferases as targets for cancer therapy

K Ghoshal, S Bai - Drugs of Today, 2007 - ohiostate.elsevierpure.com
Methylation of DNA at 5-position of cytosine, catalyzed by DNA methyltransferases, is the
predominant epigenetic modification in mammals. Aberrations in methylation play a causal …

DNA METHYLTRANSFERASES AS TARGETS FOR CANCER THERAPY

K Ghoshal, S Bai - Drugs of Today, 2007 - access.portico.org
Methylation of DNA at 5-position of cytosine, catalyzed by DNA methyltransferases, is the
predominant epigenetic modification in mammals. Aberrations in methylation play a causal …